Diagnostic Medical Systems (XPAR:ALDMS) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALDMS Diagnostic Medical Systems XPAR:ALDMS
66 GF Score
Price €1.21
GF Value €1.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Diagnostic Medical Systems Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Diagnostic Medical Systems Quality Rank Related Terms

XPAR:ALDMS
66GF Score
Diagnostic Medical Systems XPAR:ALDMS
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued. The current stock price of €1.21 is trading 4.8% above its estimated GF Value™ of €1.15. GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.

Key valuation signals for XPAR:ALDMS:

  • Quality Rank:
  • GF Value™: €1.15 vs. price of €1.21 (4.8% above fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnostic Medical Systems Business Description

Other Exchanges 0RIA:UKDMS1:Germany
Address 9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
66GF Score

Get the complete analysis for XPAR:ALDMS

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.21
Price
€1.15
GF Value